Glucose-dependent Insulinotropic Polypeptide (GIP): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Phase 1 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Obesity | 2 |
| Bone Disease, Metabolic | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Obese | 1 |
| Obesity and Obesity-related Medical Conditions | 1 |
| Overweight | 1 |
| Type 2 diabetes | 1 |
Recruiting trials involving Glucose-dependent Insulinotropic Polypeptide (GIP)
- A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
- Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
Common questions
How many recruiting trials involve Glucose-dependent Insulinotropic Polypeptide (GIP)?
2 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.